Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,280 | 76,444 | 91,052 | 93,286 | 72,482 |
| Marketable Securities | 123,725 | 178,415 | 205,304 | 233,552 | 281,530 |
| Receivables | 816 | 787 | 1,177 | 1,196 | 1,180 |
| TOTAL | $232,704 | $266,872 | $306,252 | $338,257 | $369,146 |
| Non-Current Assets | |||||
| PPE Net | 5,722 | 6,506 | 7,313 | 8,406 | 9,807 |
| Other Non-Current Assets | 60,451 | 62,140 | 63,813 | 66,235 | 69,830 |
| TOTAL | $66,173 | $68,646 | $71,126 | $74,641 | $79,637 |
| Total Assets | $298,877 | $335,518 | $377,378 | $412,898 | $448,783 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,746 | 2,930 | 2,289 | 3,166 | 1,857 |
| Accrued Expenses | 13,003 | 11,730 | 17,682 | 15,532 | 11,795 |
| TOTAL | $21,371 | $19,195 | $24,451 | $24,019 | $19,803 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 173 | 254 | 342 | 351 | 689 |
| Other Non-Current Liabilities | 44,095 | 45,469 | 46,794 | 48,050 | 49,281 |
| TOTAL | $44,095 | $45,469 | $46,794 | $48,163 | $49,475 |
| Total Liabilities | $65,466 | $64,664 | $71,245 | $72,182 | $69,278 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,937 | 38,821 | 38,284 | 38,219 | 38,037 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -355,574 | -312,811 | -273,094 | -233,930 | -189,796 |
| Other shareholders' equity | 66 | 246 | 652 | 621 | 400 |
| TOTAL | $233,411 | $270,854 | $306,133 | $340,716 | $379,505 |
| Total Liabilities And Equity | $298,877 | $335,518 | $377,378 | $412,898 | $448,783 |